Diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a cancer affecting the B cells, a type of lymphocyte that is responsible for producing antibodies. These cancerous white blood cells enlarge the lymph nodes and frequently migrate to the spleen, liver, bone marrow, and other organs. It is derived from white blood cells that grow in an uncontrolled, rapid manner. It is the most common form of lymphoma, comprising 25-30% of non-Hodgkin lymphomas (Padala SA et al. (2024)). This cancer occurs primarily in older individuals, although it can occur in young adults and, in rare cases, children. DLBCL can arise in virtually any part of the body and is often an aggressive malignancy. The main treatment includes chemoimmunotherapy, a combination of chemotherapy, steroids, and a targeted cancer drug (CRUK - Diffuse large B cell lymphoma).

Differential Abundance Analysis Results

This section presents the results of the differential protein abundance analysis, visualized through a volcano plot and summarized in the accompanying table for all three comparisons: 1) disease vs. healthy samples, 2) disease vs. diseases from the same class, and 3) disease vs. all other diseases.

Disease vs Healthy
Disease vs Class
Disease vs All other